Name
SH Hambaravi OÜ
Registry code
11326294
Type
OÜ - Limited Liability Company
Status
In liquidation
Foundation date
27.11.2006 (17)
Financial year
01.01-31.12
Capital
2 555.00 €
Activity
86231 - Provision of dental treatment
49 900 €
6 649 €
13%
1 511 €
(estimate is approximate)
34 545 €
1
Submitted
No tax arrears
19%
19%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Siiri Haugas 21.10.1960 (64) | 60% - 1 533.00 EUR | Liquidator | - | |
| Mart Haugas 05.09.1960 (64) | 40% - 1 022.00 EUR | - | - | |
| Alphaline Consult OÜ 11226888 | - | - | - | Founder |
| 2019 08.04.2020 | 2020 02.04.2021 | 2021 05.03.2022 | 2022 16.04.2023 | 2023 18.12.2023 | |
|---|---|---|---|---|---|
| Total Revenue | 46 508 € | 42 247 € | 48 311 € | 51 792 € | 49 900 € |
| Net profit (loss) for the period | 3 263 € | 1 271 € | 5 558 € | 4 224 € | 6 649 € |
| Profit Margin | 7% | 3% | 12% | 8% | 13% |
| Current Assets | 21 247 € | 22 768 € | 28 305 € | 32 340 € | 34 545 € |
| Fixed Assets | - | - | - | - | - |
| Total Assets | 21 247 € | 22 768 € | 28 305 € | 32 340 € | 34 545 € |
| Current Liabilities | 4 405 € | 4 655 € | 4 633 € | 4 444 € | 0 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 16 842 € | 18 113 € | 23 672 € | 27 896 € | 34 545 € |
| Employees | 1 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2023 Q4 | - | 2 799.6 € | 3 035.22 € | - |
| 2023 Q3 | - | 3 732.8 € | 4 046.96 € | 2 |
| 2023 Q2 | - | 2 799.6 € | 3 035.22 € | 2 |
| 2023 Q1 | - | 2 799.6 € | 3 035.22 € | 2 |
| 2022 Q4 | - | 2 799.6 € | 3 035.22 € | 2 |
| 2022 Q3 | - | 3 549.82 € | 3 848.58 € | 2 |
| 2022 Q2 | - | 2 616.62 € | 2 836.84 € | 2 |
| 2022 Q1 | - | 2 250.66 € | 2 440.08 € | 2 |
| 2021 Q4 | - | 2 250.66 € | 2 440.08 € | 2 |
| 2021 Q3 | - | 3 228.38 € | 3 544.08 € | 2 |
| 2021 Q2 | - | 2 250.66 € | 2 440.08 € | 2 |
| 2021 Q1 | - | 2 250.66 € | 2 440.08 € | 2 |
| 2020 Q4 | - | 2 250.66 € | 2 440.08 € | 2 |
| 2020 Q3 | - | 2 739.52 € | 2 992.08 € | 2 |
| 2020 Q2 | - | 1 701.72 € | 1 844.94 € | 2 |
| 2020 Q1 | - | 2 250.66 € | 2 440.08 € | 2 |
